Clinical Trial Update: A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) [Phase 3]

View source ↗

Summary

Phase 3 BRAVO trial evaluating ranibizumab injections for macular edema due to branch retinal vein occlusion; trial results demonstrate efficacy and safety data…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2011-02-25